SCHEMBL25263170

SCHEMBL25263170

CC(C)(C)OC(=O)CCCCn1cccc1C(=O)OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
ALDH1A1 P00352 9/20 0.41
KMT2A Q03164 3/20 0.41
CYP3A4 P08684 3/20 0.41
KDM4E B2RXH2 3/20 0.41
LMNA P02545 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MAPT P10636 3/20 0.41
MEN1 O00255 2/20 0.41
TDP1 Q9NUW8 3/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A3 Q01959 1/20 0.39
SYK P43405 1/20 0.39
TSHR P16473 5/20 0.38
MAPK1 P28482 3/20 0.38
ALOX15 P16050 1/20 0.38
CASP1 P29466 1/20 0.38
HTT P42858 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25394242 0.83 HDAC8 (0.39) NPC1RAB9AALDH1A1KMT2ALMNA
SCHEMBL29020291 0.82 ALDH1A1 (0.52) NPC1RAB9AALDH1A1KMT2ACYP3A4
SCHEMBL29020275 0.81 ALDH1A1 (0.53) NPC1RAB9AALDH1A1KMT2ACYP3A4
SCHEMBL25395276 0.80 CNR2 (0.37) NPC1RAB9AALDH1A1KMT2ALMNA
SCHEMBL25392985 0.79 SIGMAR1 (0.38) KMT2ACNR2L3MBTL1
SCHEMBL22481266 0.79 ALDH1A1 (0.53) ALDH1A1KMT2ALMNAMAPTTDP1
SCHEMBL29020239 0.78 RAB9A (0.51) NPC1RAB9AALDH1A1KMT2ACYP3A4
SCHEMBL12990128 0.76 ALDH1A1 (0.53) ALDH1A1KMT2ALMNAMAPTTDP1
SCHEMBL25393843 0.75 SIGMAR1 (0.38) KMT2AL3MBTL1
SCHEMBL22121563 0.75 MAPT (0.44) NPC1RAB9AALDH1A1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230286973-A1 PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2023-09-14 US disclosed
EP-4204417-A1 PROTEIN SECRETION INHIBITORS Kezar Life Sciences (US) 2023-07-05 EP disclosed
CN-116194455-A Protein secretion inhibitor 科智生命科学公司 2023-05-30 CN disclosed
WO-2022047347-A1 PROTEIN SECRETION INHIBITORS KEZAR LIFE SCIENCES (US) 2022-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230286973-A1 PROTEIN SECRETION INHIBITORS SEC61B, SEC61A1, SEC61G NPC1 369/4885RAB9A 277/4885ALDH1A1 4729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.